0001454124
2012-01-01
2012-12-31
0001454124
2011-12-31
0001454124
2010-12-31
0001454124
2011-01-01
2011-12-31
0001454124
2010-01-01
2010-12-31
0001454124
2008-11-17
2011-12-31
0001454124
2008-12-31
0001454124
2009-12-31
0001454124
2008-11-18
2011-12-31
0001454124
us-gaap:CommonStockMember
2008-11-17
2008-12-31
0001454124
us-gaap:CommonStockMember
2010-01-01
2010-12-31
0001454124
us-gaap:CommonStockMember
2011-01-01
2011-12-31
0001454124
us-gaap:CommonStockMember
2008-12-31
0001454124
us-gaap:CommonStockMember
2009-12-31
0001454124
us-gaap:CommonStockMember
2010-12-31
0001454124
us-gaap:CommonStockMember
2011-12-31
0001454124
us-gaap:AdditionalPaidInCapitalMember
2008-11-17
2008-12-31
0001454124
us-gaap:AdditionalPaidInCapitalMember
2010-01-01
2010-12-31
0001454124
us-gaap:AdditionalPaidInCapitalMember
2011-01-01
2011-12-31
0001454124
us-gaap:AdditionalPaidInCapitalMember
2008-12-31
0001454124
us-gaap:AdditionalPaidInCapitalMember
2009-12-31
0001454124
us-gaap:AdditionalPaidInCapitalMember
2010-12-31
0001454124
us-gaap:AdditionalPaidInCapitalMember
2011-12-31
0001454124
us-gaap:EquitySecuritiesMember
2008-11-17
2008-12-31
0001454124
us-gaap:EquitySecuritiesMember
2009-01-01
2009-12-31
0001454124
us-gaap:EquitySecuritiesMember
2008-12-31
0001454124
us-gaap:EquitySecuritiesMember
2009-12-31
0001454124
us-gaap:EquitySecuritiesMember
2010-12-31
0001454124
us-gaap:EquitySecuritiesMember
2011-12-31
0001454124
us-gaap:RetainedEarningsMember
2008-11-17
2008-12-31
0001454124
us-gaap:RetainedEarningsMember
2009-01-01
2009-12-31
0001454124
us-gaap:RetainedEarningsMember
2010-01-01
2010-12-31
0001454124
us-gaap:RetainedEarningsMember
2011-01-01
2011-12-31
0001454124
us-gaap:RetainedEarningsMember
2008-12-31
0001454124
us-gaap:RetainedEarningsMember
2009-12-31
0001454124
us-gaap:RetainedEarningsMember
2010-12-31
0001454124
us-gaap:RetainedEarningsMember
2011-12-31
0001454124
us-gaap:NoncontrollingInterestMember
2011-01-01
2011-12-31
0001454124
us-gaap:NoncontrollingInterestMember
2011-12-31
0001454124
2008-11-17
2008-12-31
0001454124
2009-01-01
2009-12-31
0001454124
2012-03-29
0001454124
2011-06-30
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
5Barz International, Inc.
0001454124
10-K
2011-12-31
false
--12-31
No
No
Yes
Smaller Reporting Company
FY
2011
0.001
0.001
250000000
250000000
90182785
87569800
90182785
87569800
49209
0
1274
68368
0
250152
0
170000
0
2303802
1883650
2376355
1883650
236446
15220
1196701
1439566
1541498
1463388
120437
434997
1661935
1898385
90183
87570
1458086
-49075
834377
53230
2376355
1883650
19159
4185
0
1883650
1883650
0
8602
53033
0
55318
0
528
0
606
175
1053
41982
285
43397
226741
229741
534777
29357
580990
804106
29817
855181
-804106
-29817
-855181
16666
16666
6803
695
4648
-781147
-29122
-834377
-781147
-29122
-834377
-834377
-0.0087
-0.0004
90182785
72012537
-781
-781
-271
-271
-271
221226
14970
236446
22833
0
22833
-502474
-14152
-540484
1883650
1883650
-4653
0
-4653
-175181
-1882757
-2058831
726865
1895635
2648525
49209
-1274
49209
41982
285
43397
469
469
-19159
-19159
53033
0
53033
-170000
0
-170000
-528
0
-528
893
0
-250152
0
-250152
42500
0
42500
1439079
13650
1477574
714420
-14735
19532
737
8876
8876
87570
90183
15969
15969
-49075
1458086
-425
0
-4888
-24108
-53230
-834377
527
-5144
7422
3458
-8602
-8602
76625
76625
-425
425
-425
425
-324576
0
1549987
-242865
1874563
-242865
7100000
1776100
15600000
2182290
8876100
8876100
87569800
90182785
150893700
-87800000
1360440
13650
1776
15600
2182
15969
-1950
1358258
17745
-87800
87800
150894
-150894
7100
7100
-781147
-29122
-4888
-19220
-29122
-781147
-4888
-19220
75000
7500
75
7425
355695
71139
356
70782
527
527
70696
70696
103778283
21739464
<p style="margin: 0pt"></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b>Note 1 – Organization and basis of reporting</b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">The Company was incorporated under the laws of the State
of Nevada on November 17, 2008. At that time, the Company held certain technology related to bio-degradable product and operated
under the name “Bio-Stuff”.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On December 29, 2010 the Company changed its name to 5BARz
International, Inc. and on December 30, 2010, the Company acquired a set of agreements through which the Company acquired from
Cellynx Group, Inc. certain intellectual property underlying the 5BARz products, a highly engineered microcell technology referred
to as a “cellular network infrastructure device”. The 5BARz device captures cell signal and provides a smart amplification
and resend of that cell signal giving the user improved cellular reception in their home, office or while mobile. Pursuant to the
agreements referred to above, the Company was engaged as the exclusive agent for the global sales and marketing of the 5BARz products.
On March 29, 2012, 5Barz International, Inc. acquired a 60% controlling interest in Cellynx Group, Inc.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On November 6, 2011, the Company incorporated a subsidiary
Company in Zurich, Switzerland called 5BARz AG which is a 99.5% held subsidiary at December 31, 2011. That entity has been licensed
the marketing and distribution rights for 5BARz products in Germany, Austria and Switzerland. These financial statements reflect
the financial position and results of operations for the Company and its subsidiary 5BARz Ag, from inception to date.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Going concern </u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">These financial statements have been prepared on a going
concern basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal course
of business.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">At December 31, 2011, the Company was engaged in a business
and had suffered losses from development stage activities to date. In addition, the Company has minimal operating funds. Although
management is currently developing its sales and marketing program for the sales of 5BARz product, the Company has made no revenue
to date.  The Company is seeking additional sources of equity or debt financing, and there is no assurance these activities
will be successful. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The
financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Development stage </u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">The Company has been in the development stage since its formation
and has not yet realized any revenues from its planned operations.</p>
<p style="margin: 0pt"> </p>
<p style="margin: 0pt"></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b>Note 2 - Summary of significant accounting policies</b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Basis of presentation</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b> </b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">The accompanying consolidated financial statements have been
prepared in accordance with accounting principles generally accepted in the United States of America. The accompanying consolidated
financial statements include the accounts of 5Barz International Inc., and its 99.5% owned subsidiary, 5Barz AG. All intercompany
accounts and transactions have been eliminated upon consolidation. Changes in classification of 2010 amounts have been made to
conform to current presentations.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Cash</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Cash and cash equivalents include cash in hand and cash in
time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Use of estimates</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">The preparation of financial statements in conformity with
accounting principles generally accepted in the United States of America requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ
from those estimates.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Concentration of credit risk</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Cash includes deposits in accounts maintained at financial
institutions.  Certain financial instruments, which subject the Company to concentration of credit risk, consist of cash.
The Company maintains balances at financial institutions which, from time to time, may exceed Federal Deposit Insurance Corporation
insured limits for the banks located in the United States. As of December 31, 2011 and 2010, the Company did not have any deposits
in excess of federally-insured limits.  To date, the Company has not experienced any losses in such accounts.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Equipment</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Equipment is recorded at historical cost and is depreciated
using the straight-line method over their estimated useful lives.  The useful life and depreciation method are reviewed
periodically to ensure that the depreciation method and period are consistent with the anticipated pattern of future economic benefits.
Expenditures for maintenance and repairs are charged to operations as incurred while renewals and betterments are capitalized.
Gains and losses on disposals are included in the results of operations. The useful life of the equipment is being depreciated
over three to five years.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Intangible assets</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Acquired patents, licensing rights and trademarks are capitalized
at their acquisition cost or fair value. The legal costs, patent registration fees, and models and drawings required for filing
patent applications are capitalized if they relate to commercially viable technologies. Commercially viable technologies are those
technologies that are projected to generate future positive cash flows in the near term. Legal costs associated with applications
that are not determined to be commercially viable are expensed as incurred. All research and development costs incurred in developing
the patentable idea are expensed as incurred. Legal fees from the costs incurred in successful defense to the extent of an evident
increase in the value of the patents are capitalized.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Capitalized costs for patents are amortized on a straight-line
basis over the remaining twenty-year legal life of each patent after the costs have been incurred. Once each patent or trademark
is issued, capitalized costs are amortized on a straight-line basis over a period not to exceed 20 years and 10 years, respectively.
All research and development costs incurred in developing the patentable idea are expensed as incurred. The licensing right is
amortized on a straight-line basis over a period of 10 years.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Impairment or disposal of long-lived assets</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">The Company applies the provisions of Accounting Standards
Codification (“ASC”) Topic 360, “Property, Plant, and Equipment,” which addresses financial accounting
and reporting for the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived
assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by
those assets are less than the assets’ carrying amounts. In that event, a loss is recognized based on the amount by which
the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined
in a similar manner, except that fair values are reduced for the cost of disposal. Based on its review, the Company believes that
as of December 31, 2011 and December 31, 2010, there was no significant impairment of its long-lived assets.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">  </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Revenue recognition</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">The Company's revenue recognition policies are in compliance
with ASC Topic 605, “Revenue Recognition.”  Revenue is recognized at the date of shipment to customers, and
when the price is fixed or determinable, the delivery is completed, no other significant obligations of the Company exist and collectability
is reasonably assured.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Foreign currency translation</u></b></p>
<p style="font: 10pt/normal Arial, Helvetica, Sans-Serif; margin: 0"><b> </b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Transactions in foreign currencies have been translated into
US dollars using the temporal</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">method. Under this method, monetary assets and liabilities
are translated at the year-end exchange</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">rate. Non-monetary assets have been translated at the historical
rate of exchange prevailing at the</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">date of the transaction. Expenses have been translated at
the exchange rate at the time of the</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">transaction. Realized and unrealized foreign exchange gains
and losses are included in operations.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Fair value of financial instruments</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">We have adopted Accounting Standards Codification regarding
<i>Disclosure About Derivative Financial Instruments and Fair Value of Financial Instruments</i>. The carrying amounts of cash,
accounts payable, accrued expenses, and other current liabilities approximate fair value because of the short maturity of these
items. These fair value estimates are subjective in nature and involve uncertainties and matters of significant judgment, and,
therefore, cannot be determined with precision. Changes in assumptions could significantly affect these estimates.  We
do not hold or issue financial instruments for trading purposes, nor do we utilize derivative instruments in the management of
foreign exchange, commodity price or interest rate market risks.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b> </b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Income taxes</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">The Company accounts for income taxes in accordance with
ASC Topic 740, “Income Taxes.” ASC 740 requires a company to use the asset and liability method of accounting for income
taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized
for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities
and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely
than not that some portion, or all of, the deferred tax assets will not be realized.  Deferred tax assets and liabilities
are adjusted for the effects of changes in tax laws and rates on the date of enactment.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Under ASC 740, a tax position is recognized as a benefit
only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination
being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized
on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The adoption
had no effect on the Company’s financial statements.  Penalties and interest incurred related to underpayment of
income tax are classified as income tax expense in the period incurred.  No significant penalties or interest relating
to income taxes have been incurred during the years ended December 31, 2011 and 2010.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Net loss per share</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">The Company reports loss per share in accordance with the
ASC Topic 260, “Earnings Per Share.” , which requires presentation of basic and diluted EPS on the face of the
income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator
of the basic EPS computation to the numerator and denominator of the diluted EPS computation.  In the accompanying financial
statements, basic earnings per share of common stock is computed by dividing net income by the weighted average number of shares
of common stock outstanding during the period.  We do not have a complex capital structure requiring the computation
of diluted earnings per share.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Recent accounting pronouncements</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">In December 2010, the FASB issued updated guidance on when
and how to perform certain steps of the periodic goodwill impairment test for public entities that may have reporting units with
zero or negative carrying amounts. This guidance is effective for fiscal years, and interim periods within those years, beginning
after December 15, 2010, with early adoption prohibited.  The adoption of this standard update did not impact the Company’s
consolidated financial statements.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">In May 2011, the FASB issued guidance to amend certain measurement
and disclosure requirements related to fair value measurements to improve consistency with international reporting standards. This
guidance is effective prospectively for public entities for interim and annual reporting periods beginning after December 15, 2011,
with early adoption by public entities prohibited. The Company is currently evaluating this guidance, but does not expect its adoption
will have a material effect on its consolidated financial statements.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">In June 2011, the FASB issued new guidance on the presentation
of comprehensive income that will require a company to present components of net income and other comprehensive income in one continuous
statement or in two separate, but consecutive statements. There are no changes to the components that are recognized in net income
or other comprehensive income under current GAAP. This guidance is effective for fiscal years, and interim periods within those
fiscal years, beginning after December 15, 2011, with early adoption permitted.  The Company is currently evaluating
this guidance, but does not expect its adoption will have a material effect on its consolidated financial statements.</p>
<p style="margin: 0pt"> </p>
<p style="margin: 0pt"></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b>Note 3 – Equipment</b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Equipment consisted of the following at December 31, 2011
and December 31, 2010:</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom; background-color: white">
<td style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td colspan="2" style="line-height: 115%; text-align: center">December 31,</td>
<td nowrap="nowrap" style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td colspan="2" style="line-height: 115%; text-align: center">December 31,</td>
<td nowrap="nowrap" style="line-height: 115%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center">2011</td>
<td nowrap="nowrap" style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; text-align: center">2010</td>
<td nowrap="nowrap" style="line-height: 115%"> </td></tr>
<tr style="background-color: #CCEEFF">
<td style="width: 70%; vertical-align: bottom; line-height: 115%">Computer equipment</td>
<td style="width: 1%; vertical-align: bottom; line-height: 115%"> </td>
<td style="width: 1%; vertical-align: bottom; line-height: 115%">$</td>
<td style="width: 12%; vertical-align: bottom; line-height: 115%; text-align: right">4,653</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; line-height: 115%"> </td>
<td style="width: 1%; vertical-align: bottom; line-height: 115%"> </td>
<td style="width: 1%; vertical-align: bottom; line-height: 115%">$</td>
<td style="width: 12%; vertical-align: top; line-height: 115%; text-align: center">0</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; line-height: 115%"> </td></tr>
<tr style="background-color: white">
<td style="vertical-align: bottom; line-height: 115%">Accumulated depreciation</td>
<td style="vertical-align: bottom; line-height: 115%"> </td>
<td style="vertical-align: bottom; border-bottom: black 1pt solid; line-height: 115%"> </td>
<td style="vertical-align: bottom; border-bottom: black 1pt solid; line-height: 115%; text-align: right">(468</td>
<td nowrap="nowrap" style="vertical-align: bottom; line-height: 115%">)</td>
<td style="vertical-align: bottom; line-height: 115%"> </td>
<td style="vertical-align: bottom; border-bottom: black 1pt solid; line-height: 115%"> </td>
<td style="vertical-align: top; border-bottom: black 1pt solid; line-height: 115%; text-align: center">0</td>
<td nowrap="nowrap" style="vertical-align: bottom; line-height: 115%; font-size: 12pt"> </td></tr>
<tr style="background-color: #CCEEFF">
<td style="vertical-align: bottom; line-height: 115%">Equipment, net</td>
<td style="vertical-align: bottom; line-height: 115%"> </td>
<td style="vertical-align: bottom; border-bottom: black 1.5pt double; line-height: 115%">$</td>
<td style="vertical-align: bottom; border-bottom: black 1.5pt double; line-height: 115%; text-align: right">4,185</td>
<td nowrap="nowrap" style="vertical-align: bottom; line-height: 115%"> </td>
<td style="vertical-align: bottom; line-height: 115%"> </td>
<td style="vertical-align: bottom; border-bottom: black 1.5pt double; line-height: 115%">$</td>
<td style="vertical-align: top; border-bottom: black 1.5pt double; line-height: 115%; text-align: center">0</td>
<td nowrap="nowrap" style="vertical-align: bottom; line-height: 115%"> </td></tr>
</table>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="margin: 0pt"> </p>
<p style="margin: 0pt"></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b>Note 4 – Intangible Assets</b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b> </b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On December 30, 2010 the Company acquired a 50% interest
in the patents and trademarks which comprise the 5Barz technology owned and developed by Cellynx Group, Inc. These intangible assets
were acquired for aggregate proceeds of $1,883,650 comprised of a note payable in the amount of $1,500,000 to Cellynx Group, Inc.,
a note payable due to Dollardex Group Corp in the amount of $370,000 and 15,600,000 shares issued at a valuation of $13,650.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">During the year ended December 31, 2011 no amortization has
been recorded on the intangible assets.</p>
<p style="margin: 0pt"> </p>
<p style="margin: 0pt"></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 5 - Federal income tax: </b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">The Company has provided no current income taxes due to the
losses incurred from November 17, 2008 (date of inception), through December 31, 2011. Net operating losses of approximately $708,000
at December 31, 2011, are available for carryover. The net operating losses will expire from 2028 through 2031. The
Company has provided a 100% valuation allowance for the deferred tax benefit resulting from the net operating loss carryover
due to our limited operating history. In addressing the ability to realize the benefit of deferred tax assets, management
considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The
ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which
those temporary differences are deductible. When we demonstrate a history of profitable operation, we will reduce our valuation
allowance at that time.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">A reconciliation of the statutory Federal income tax rate
and the effective income tax rate for the years ended December 31, 2011 and 2010 follows:</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
<td style="line-height: 115%"> </td>
<td style="line-height: 115%; font-weight: bold"> </td>
<td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center">December 31,</td>
<td nowrap="nowrap" style="line-height: 115%; font-weight: bold; text-align: center"> </td>
<td style="line-height: 115%; font-weight: bold; text-align: center"> </td>
<td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center">December 31,</td>
<td nowrap="nowrap" style="line-height: 115%; font-weight: bold"> </td></tr>
<tr style="vertical-align: bottom">
<td style="line-height: 115%"> </td>
<td style="line-height: 115%; font-weight: bold"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; line-height: 115%; font-weight: bold; text-align: center">2011</td>
<td nowrap="nowrap" style="line-height: 115%; font-weight: bold"> </td>
<td style="line-height: 115%; font-weight: bold"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; line-height: 115%; font-weight: bold; text-align: center">2010</td>
<td nowrap="nowrap" style="line-height: 115%; font-weight: bold"> </td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
<td style="width: 72%; line-height: 115%">Statutory federal income tax rate</td>
<td style="width: 1%; line-height: 115%"> </td>
<td style="width: 1%; line-height: 115%"> </td>
<td style="width: 11%; line-height: 115%; text-align: right">(34%</td>
<td nowrap="nowrap" style="width: 1%; line-height: 115%">)</td>
<td style="width: 1%; line-height: 115%"> </td>
<td style="width: 1%; line-height: 115%"> </td>
<td style="width: 11%; line-height: 115%; text-align: right">(34%</td>
<td nowrap="nowrap" style="width: 1%; line-height: 115%">)</td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="line-height: 115%; text-align: right"> </td>
<td nowrap="nowrap" style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="line-height: 115%; text-align: right"> </td>
<td nowrap="nowrap" style="line-height: 115%"> </td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
<td style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="line-height: 115%; text-align: right"> </td>
<td nowrap="nowrap" style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="line-height: 115%; text-align: right"> </td>
<td nowrap="nowrap" style="line-height: 115%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="line-height: 115%; text-align: right"> </td>
<td nowrap="nowrap" style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="line-height: 115%; text-align: right"> </td>
<td nowrap="nowrap" style="line-height: 115%"> </td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
<td style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="line-height: 115%; text-align: right"> </td>
<td nowrap="nowrap" style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="line-height: 115%; text-align: right"> </td>
<td nowrap="nowrap" style="line-height: 115%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="line-height: 115%">Valuation allowance</td>
<td style="line-height: 115%"> </td>
<td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td>
<td style="border-bottom: black 1.5pt solid; line-height: 115%; text-align: right">34%</td>
<td nowrap="nowrap" style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td>
<td style="border-bottom: black 1.5pt solid; line-height: 115%; text-align: right">   34 %</td>
<td nowrap="nowrap" style="line-height: 115%"> </td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
<td style="line-height: 115%">Effective income tax rate</td>
<td style="line-height: 115%"> </td>
<td style="border-bottom: black 2.25pt double; line-height: 115%"> </td>
<td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">-</td>
<td nowrap="nowrap" style="line-height: 115%; text-align: right"> </td>
<td style="line-height: 115%; text-align: right"> </td>
<td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right"> </td>
<td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">-</td>
<td nowrap="nowrap" style="line-height: 115%"> </td></tr>
</table>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">The significant components of deferred tax assets and liabilities
are as follows:</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom">
<td style="line-height: 115%"> </td>
<td style="line-height: 115%; font-weight: bold"> </td>
<td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center">December 31,</td>
<td nowrap="nowrap" style="line-height: 115%; font-weight: bold; text-align: center"> </td>
<td style="line-height: 115%; font-weight: bold; text-align: center"> </td>
<td colspan="2" style="line-height: 115%; font-weight: bold; text-align: center">December 31,</td>
<td nowrap="nowrap" style="line-height: 115%; font-weight: bold"> </td></tr>
<tr style="vertical-align: bottom">
<td style="line-height: 115%"> </td>
<td style="line-height: 115%; font-weight: bold"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; line-height: 115%; font-weight: bold; text-align: center">2011</td>
<td nowrap="nowrap" style="line-height: 115%; font-weight: bold"> </td>
<td style="line-height: 115%; font-weight: bold"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; line-height: 115%; font-weight: bold; text-align: center">2010</td>
<td nowrap="nowrap" style="line-height: 115%; font-weight: bold"> </td></tr>
<tr style="vertical-align: bottom">
<td style="line-height: 115%">Deferred tax assets:</td>
<td style="line-height: 115%"> </td>
<td colspan="2" style="line-height: 115%"> </td>
<td nowrap="nowrap" style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td colspan="2" style="line-height: 115%"> </td>
<td nowrap="nowrap" style="line-height: 115%"> </td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
<td style="width: 72%; line-height: 115%">Net operating loss carry-forwards</td>
<td style="width: 1%; line-height: 115%"> </td>
<td style="width: 1%; line-height: 115%">$</td>
<td style="width: 11%; line-height: 115%; text-align: right">222,282</td>
<td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td>
<td style="width: 1%; line-height: 115%"> </td>
<td style="width: 1%; line-height: 115%">$</td>
<td style="width: 11%; line-height: 115%; text-align: right">10,179</td>
<td nowrap="nowrap" style="width: 1%; line-height: 115%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="line-height: 115%">Valuation allowance</td>
<td style="line-height: 115%"> </td>
<td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td>
<td style="border-bottom: black 1.5pt solid; line-height: 115%; text-align: right">(222,282</td>
<td nowrap="nowrap" style="line-height: 115%">)</td>
<td style="line-height: 115%"> </td>
<td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td>
<td style="border-bottom: black 1.5pt solid; line-height: 115%; text-align: right">(10,179</td>
<td nowrap="nowrap" style="line-height: 115%">)</td></tr>
<tr style="vertical-align: bottom; background-color: #EEEEEE">
<td style="line-height: 115%">Net deferred tax assets</td>
<td style="line-height: 115%"> </td>
<td style="border-bottom: black 2.25pt double; line-height: 115%">$</td>
<td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">-</td>
<td nowrap="nowrap" style="line-height: 115%"> </td>
<td style="line-height: 115%"> </td>
<td style="border-bottom: black 2.25pt double; line-height: 115%">$</td>
<td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">-</td>
<td nowrap="nowrap" style="line-height: 115%"> </td></tr>
</table>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="margin: 0pt"> </p>
<p style="margin: 0pt"></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 13.15pt"><b>Note 6 - Cumulative sales of stock: </b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 13.15pt">Since its inception, we have issued shares of common
stock as follows:</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify">On November 17, 2008, our
Directors authorized the issuance of 7,100,000 founder shares at par value of $0.001. These shares are restricted under rule 144
of the Securities Exchange Commission.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify">On various days in December
2008, our Directors authorized the issuance of 1,776,100 shares of common stock at a price of $0.01 per share as fully paid and
non-assessable to the subscriber. These shares are not restricted and are free trading.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify">On November 15, 2010, our
Directors initiated a forward stock split of 18:1 and increased the authorized shares from 100,000,000 to 250,000,000</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify">On December 30, 2010, the
Directors approved the cancellation of 87,800,000 shares of common stock.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On December 31, 2010, the Directors issued 15,600,000 shares
in conjunction with the acquisition of certain assets, more fully described in Note 7</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On January 10, 2011 the Company issued 300,000 shares of
common stock at a price of $1.00 per share for aggregate proceeds of $300,000.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On January 15, 2011 the Company issued 200,000 shares of
common stock at a price of $1.00 per share for aggregate proceeds of $200,000.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On March 9, 2011 the Company issued 150,000 shares of common
stock at a price of $1.00 per share for aggregate proceeds of $150,000.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On April 4, 2011 the Company issued 350,000 shares of common
stock at a price of $1.00 per share for aggregate proceeds of $350,000.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On April 7, 2011 the Company issued 200,000 shares of common
stock at a price of $1.00 per share for aggregate proceeds of $200,000.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On June 3, 2011 the Company issued 5,000 shares of common
stock at a price of $0.70 per share for aggregate proceeds of $3,500.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On July 18, 2011 the Company issued 25,000 shares of common
stock at a price of $1.00 per share for aggregate proceeds of $25,000.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On July 21, 2011 the Company issued 69,610 shares of common
stock at a price of $0.20 per share for aggregate proceeds of $14,000.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On July 24, 2011 the Company issued 40,000 shares of common
stock at a price of $0.20 per share for aggregate proceeds of $7,500.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On November 8, 2011 the Company issued 200,000 shares of
common stock at a price of $0.15 per share for aggregate proceeds of $30,000.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On November 8, 2011 the Company issued 200,000 shares of
common stock at a price of $0.15 per share for aggregate proceeds of $30,000.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On December 7, 2011 the Company issued 75,000 shares of common
stock at a price of $0.10 per share for services provided in the amount of $7,500.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On December 15, 2011 the Company issued 455,180 shares of
common stock at a price of $0.10 per share for aggregate proceeds of $45,518.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On December 1, 2011 the Company issued 355,695 shares of
common stock at a price of $0.20 per share for conversion of a Convertible Debenture Agreement, dated August 15,2011for a principal
amount of <font style="color: black">Fifty Thousand Euros (€50,000), which </font>bears interest at a rate of 8.5%.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On December 19, 2011 the Company issued 150,000 shares of
common stock at a price of $0.10 per share for aggregate proceeds of $15,000.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">In December 2011, 5BARz AG sold 22,000 common shares with
a par value of 0.01 per share, at a price of CHF 3.00 ($3.26 US) per share, for aggregate proceeds of CHF 66,000 (US – $70,700).
The proceeds received have been credited to additional paid in capital in these consolidated financial statements.</p>
<p style="margin: 0pt"> </p>
<p style="margin: 0pt"></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt"><b>Note 7 - Asset acquisition agreement:</b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify">On December 31, 2010, the
Company entered into three agreements as follows;</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify">(i)<font style="font-size: 7pt">                
</font>An “Amended and Restated Master Global Marketing and Distribution Agreement.”</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify">(ii)<font style="font-size: 7pt">              
</font>An asset purchase agreement</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify">(iii)<font style="font-size: 7pt">            
</font>A line of credit agreement <font style="font-size: 12pt">and</font> security agreement</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify">The agreements relate principally
to the development of the marketing and distribution of the 5BARz line of products and related accessories and a 50% ownership
interest in the 5BARz intellectual property.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 13.15pt; text-align: justify">The agreements were assigned
from Dollardex Group Corp, to the Company for proceeds of $383,650, which is comprised of a note payable in the amount of $370,000
and the issuance of 15,600,000 shares of common stock . The note payable bears interest at a rate of 5% and has no specific terms
of repayment.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Pursuant to the terms of the asset purchase agreement, as
amended the Company is obligated to a series of payments to the Cellynx Group, Inc. for a ½ interest in the 5BARz intellectual
property for aggregate payments of $1,500,000. Subsequent to December 31, 2011 that agreement was further amended such that 5Barz
International acquired a 60% interest in that intellectual property by the issuance on March 29, 2012 of 9,000,0000 shares of the
registrant.</p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Pursuant to the Master Global Marketing and Distribution
agreement assigned the registrant was obligated to pay to Cellynx Group, Inc a royalty fee amounting to 50% of the Company’s
Net Earnings. That fee would be paid on a quarterly basis, payable in cash or immediately available funds and shall be due and
payable not later than 45 days following the end of each calendar quarter of the year. Subsequent to year end, the asset acquisition
agreement specified that the royalties would be paid in relation to the ownership of the intellectual property. Accordingly as
Cellynx Group, Inc. owns 40% of that intellectual property, Cellynx would be entitled to 40% of the 50% royalty fee.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Subsequent to the year end, on March 29, 2012, the Company
acquired a 60% interest in the common stock of Cellynx Group Inc. such that Cellynx will be a consolidated subsidiary of the registrant.
(See subsequent events note)</p>
<p style="margin: 0pt"> </p>
<p style="margin: 0pt"></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 13.15pt"><b>Note 8 – Convertible promissory notes:</b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On August 24, 2011 the Company issued a convertible debenture
to an investor for 50,000 Euros, converted at that date to $71,965 USD. The debenture had a term of 90 days and an interest rate
of 8.5%. On December 13, 2011, the holder elected to convert the outstanding principle and interest into common shares at a price
of $0.20 per share, converting $67,294 into 336,472 shares. In addition, the Company issued an additional 19,223 shares as a bonus
for conversion.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On September 20, 2011, 5BARz International Inc., (“the
Company”), completed a transaction pursuant to a Promissory Note agreement (the Note), through which the Company borrowed
$42,500. The Note bears interest at a rate of 8%, and is due on June 22, 2012, (the “Due Date”).  The Company
may settle that note within the first 90 days following the issue date by paying to the Lender 140% of the principle amount
of the note plus accrued interest. The Company may settle the note during the period which is 91 days from the issue date of the
note to 180 days from the issue date of the note by payment of 150% of the principle amount of the note plus accrued interest.
In the event that the note is not repaid 180 days from the date of issue, the note is convertible into common stock. On March 20,
2012 the note was paid and cancelled (see subsequent events note)</p>
<p style="margin: 0pt"> </p>
<p style="margin: 0pt"></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 13.15pt"><b>Note 9 - Related party transactions:</b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On December 30, 2010 the Company acquired by way of an assignment
agreement all right title and interest in a set of agreements from a Company of which the President and Director is also the President
and Director of the reporting Company. The proceeds to be paid for that assignment agreement is comprised of a note payable in
the amount of $370,000, and the issuance of 15,600,000 shares of common stock.  During the year ended December 31, 2011
the Company paid $339,382 of principle and interest on that note. At December 31, 2011 the Company had a remaining balance on that
note payable in the amount of $30,618 (2010 - $370,000). The note payable accrues interest at a rate of 5% per annum, and during
the year ended December 31, 2011, interest in the amount of $10,015 was charged pursuant to the terms of this note.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">In addition the Company had an amount due to that related
party comprised of payments made by the related party on behalf of the Company aggregating $79,804 (2010 - $64,997). That amount
due is non interest bearing and has no specific terms of repayment.</p>
<p style="margin: 0pt"> </p>
<p style="margin: 0pt"></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 10 - Commitments: </b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On December 30, 2010 the Company entered into a commitment
to provide to Cellynx Group, Inc., the co-owner of the Company’s intellectual property a revolving line of credit in the
amount of $2.5 million dollars. That revolving line of credit accrues interest at a rate of 6% per annum.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">During the year ended December 31, 2011 the registrant paid
to Cellynx Group, Inc. $233,500 and accrued interest in the amount of $16,651, pursuant to the terms of that revolving line of
credit agreement. At December 31, 2011 the commitment to fund Cellynx Group Inc. aggregated $2,249,849.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Subsequent to the year end, on March 29, 2012 the Company
entered into an addendum agreement with Cellynx Group, Inc. related to the revolving line of credit agreement. That addendum agreement
reallocated $346,049 paid by the Company to Cellynx Group, Inc. under the asset purchase agreement, to the revolving line of credit
resulting in a combined funding to the date of the addendum agreement of $596,200. In addition, the addendum agreement provided
to 5BARz, the right to convert amounts advanced under the line of credit agreement to common shares in Cellynx, on a conversion
basis which is equal to that offered by Cellynx to certain other creditors. That conversion basis is calculated as 25% of the volume
weighted average bid price of the common stock for a period of 10 days prior to the conversion notice. On March 29, 2012 the addendum
agreement further specified the commitment to fund Cellynx Group, Inc. to be $2.2 million dollars prior to maturity of the revolving
line of credit agreement on October 5, 2013.  </p>
<p style="margin: 0pt"> </p>
<p style="margin: 0pt"></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b>NOTE 11 - Formation of subsidiary company, 5BARz AG</b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On October 6, 2011, the Company commenced the organization
of a subsidiary Company under the laws of Switzerland, in the Canton of Zurich, called 5BARz AG. 5BARz AG issued 10,000,000 common
shares of which 5,100,000 are held by the Company and 4,900,000 are held in escrow for resale, by an independent escrow agent under
the control of the Company. 5BARz AG issued the shares with a stated or par value of CHF 0.01 per share for proceeds of CHF 100,000
(US - $108,752). The net proceeds received on re-sale above the stated or par value of the shares, is paid into 5Barz AG as additional
paid in capital.<b> </b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b> </b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On October 19, 2011, the registrant, 5BARz International
Inc. entered into a Marketing and Distribution agreement with 5BARz AG, through which 5BARz AG holds the exclusive rights for the
marketing and distribution of products produced under the 5BARz<b> </b>brand for markets in Switzerland, Austria and Germany. That
agreement does not have a royalty payment requirement, and remains effective as long as 5BARz Ag is controlled by the Company.
5BARz Ag is a consolidated subsidiary of the Company in these financial statements.</p>
<p style="margin: 0pt"> </p>
<p style="margin: 0pt"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b>NOTE 12 - Stock acquisition agreement, Cellynx Group,
Inc.</b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On January 7, 2011 the Company entered into a stock purchase
agreement with two founding shareholders of Cellynx Group, Inc. to acquire in aggregate 63,412,638 shares of the capital stock
of Cellynx Group, Inc. for total proceeds of $634,126. At December 31, 2011 the Company had paid $170,000 as a deposit made under
that agreement.</p>
<p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Subsequent to the year end, on March 29, 2012 the Company
entered into a securities exchange agreement and settlement agreement with each of these two founding shareholders of Cellynx Group,
Inc. whereby in addition to the $170,000 paid, the Company issued 1,250,000 shares of common stock of the issuer in exchange for
the 63,412,638 shares of Cellynx Group, Inc.</p>
<p style="margin: 0pt"></p>
<p style="margin: 0pt"></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 13 - Subsequent events</b></p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b> </b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Addendum agreement between 5Barz International, Inc.
and Cellynx Group, Inc.</u></b></p>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On March 29, 2012, the Company entered into an Addendum Agreement
with Cellynx Group, Inc. related to a set of agreements dated October 5, 2010 and assigned to the registrant on December 30, 2010.
These Agreements are comprised of an “Asset Purchase Agreement”, an “Amended and Restated Master Global Marketing
and Distribution Agreement” and a “Revolving Line of Credit Agreement”.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Pursuant to that addendum agreement, the company increased
the registrant’s percentage ownership of the Intellectual Property comprising the 5BARz technology from a 50% interest to
a 60% interest. In addition, the Registrant agreed to the issuance of 9,000,000 common shares in the capital of 5BARz International
Inc. at a deemed value of $0.20 per share, aggregating $1,800,000 as payment in full for the intellectual property acquired, and
has also therein clarified that the ownership interest does represent that proportionate interest in income earned from that intellectual
property.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">The terms of that “Revolving Line of Credit Agreement”
have been further revised to be convertible into common stock on a basis consistent with other debt agreements recently entered
into by Cellynx Group, Inc. In addition, the aggregate commitment of the Revolving Line of Credit Agreement has been amended to
be $2.2 Million Dollars and the period of that agreement has been extended to a maturity date of October 5, 2013.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">In furtherance to the acquisition of the intellectual property
under the “Asset Purchase Agreement” the Registrant has also assumed all responsibilities for the future, protection
and prosecution of rights under the patents and patent applications as provided there-under.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">The addendum agreement has further clarified and made current
the summary of intellectual property which is sold under the terms of the “Asset Purchase Agreement” as provided in
the schedule of intellectual property provided therein. Further the addendum agreement has deleted the right of first refusal for
Cellynx Group, Inc to reacquire that intellectual property.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Finally, the addendum agreement has restated the date of
initial interest to be paid by the borrower under the terms of the Revolving Line of Credit from October 1, 2011 to October 1,
2012.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><b><u>Securities Purchase Agreements</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Convertible debenture agreement</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b> </b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On February 3, 2012 the Company entered into a Convertible
Debenture Agreement with an investor for aggregate proceeds of $500,000 of which $100,000 is paid in cash and a promissory note
in the principal amount of $400,000 is due to the Company by no later than August 3, 2013. The debenture bears interest at a rate
of 4.75%, and is due on February 3, 2016, (the “Maturity Date”). The promissory note from the investor for $400,000
bears interest at a rate of 5%. The agreement is subject to an early pre-payment provision whereby the Company may prepay the $100,000
by May 8, 2012 and the agreements may be cancelled in their entirety.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">In the event that the convertible debenture is not prepaid,
the investor may convert the principle and unpaid interest due under the agreement 180 days from the date of the agreement at a
price which is 110% of the lesser of $1.00, or 80% of the average of the three lowest trading prices of the Company’s common
stock over the twenty one trading days prior to the date of the conversion. Such conversions are subject to a restriction such
that holder may not own greater than 4.99% of the issued and outstanding capital stock of the Company.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">If, on the
date the holder delivers a conversion notice, the applicable conversion price is below $0.06, the Company may prepay that portion
of the Debenture that Holder elected to convert in an amount equal to one hundred twenty percent (120%) of the amount to be converted.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><b> </b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><b>Equity Investment
Agreement</b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in">On February
3, 2011, in conjunction with the convertible debenture agreement referred to above the Company granted to the investor the right
to purchase of up to $5,000,000 of the Company's common stock, beginning on August 3, 2012. Such investment is limited to the
4.99% limitation on ownership in the reporting Company referred to above. In addition, the investor is required to purchase a
minimum of $50,000 per month beginning two hundred ten (210) days from the Issue Date or September 3, 2011.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><font style="text-underline-style: none"> </font></p>
<p style="font: bold 12pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left"><u>Acquisition of 60% of Cellynx
Group, Inc.</u></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On January 7, 2011 the Company entered into a securities
purchase agreement to acquire 63,412,638 shares of the common stock of Cellynx Group, Inc. (Cellynx) from two founding shareholders
of Cellynx. At that time the Company made a $170,000 deposit for that stock. On March 29, 2012, the Company completed that acquisition
of the 63,412,638 shares of Cellynx in exchange for the issuance of 1,250,000 shares of capital stock in the Company, in addition
to the $170,000 paid, pursuant to a share exchange and settlement agreement with the two founding shareholders of Cellynx Group,
Inc.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On March 29, 2012 the Company converted $73,500 due from
Cellynx, pursuant to the revolving line of credit agreement for the issuance of 350,000,000 shares of Cellynx. That acquisition
in addition to the completion of the acquisition referred to above comprises a 60% acquisition of control of Cellynx Group, Inc.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Promissory note settlement </u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On March 20, 2012, the Company paid $65,362 in full and final
settlement of the promissory note dated September 20, 2011 referred to in note 8 above.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Sales of Common Stock</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On February 1, 2012 the Company issued 1,550,000 shares of
common stock at a price of $0.10 per share for services provided in the amount of $155,000 to consultants of the Company.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On <font style="color: #333333">various days in February
2012</font> the Company issued 700,000 shares of common stock at a price of $0.10 per share for aggregate proceeds of $70,000.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On <font style="color: #333333">various days in March 2012</font>
the Company issued 636,164 shares of common stock at a price of $0.12 per share for aggregate proceeds of $76,340.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On <font style="color: #333333">various days in March 2012</font>
the Company issued 503,333 shares of common stock at a price of $0.15 per share for aggregate proceeds of $75,500.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">During the period January to March 30, 2012, 5BARz AG issued
40,000 shares of common stock at a price of CHF 3.00 (US $3.31) for aggregate proceeds of CHF 120,000 (US $132,000).</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b> </b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Convertible promissory note</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">On March 8, 2012, the Company, completed a transaction pursuant
to a Promissory Note agreement (the Note), through which the Company borrowed $37,500. The Note bears interest at a rate of 8%,
and is due 180 days from the date of issue on September 4, 2012, (the “Due Date”).  The Company may settle
that note within the first 90 days following the issue date by paying to the Lender 140% of the principle amount of the note
plus accrued interest. The Company may settle the note during the period which is 91 days from the issue date of the note to 180
days from the issue date of the note by payment of 150% of the principle amount of the note plus accrued interest.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">In the event that the note is not repaid 180 days from the
date of issue, the note is convertible into common stock. The investor may convert principal and unpaid interest on the note into
shares of the Company’s common stock, with the number of shares issuable determined by dividing the amount to be converted
by the conversion price which is equal to 55% of the average of the three lowest closing bid prices of the Company’s common
stock over the ten trading days prior to the date of the conversion.  The investor is prohibited from converting amounts
if such conversions results in investor holding more than 4.99% of the Company’s then-outstanding common stock.  No
registration rights were granted in connection with the purchase of the March 2012 Note, and the shares of common stock, if any,
issued upon conversion, will be restricted securities as defined pursuant to the terms of Rule 144.</p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b><u>Commitment to Issue Shares</u></b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0"><b> </b></p>
<p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">During February and March 2012 the Company appointed certain
senior industry executives to the Company’s advisory board to assist with the development of the Company, and the integration
of its technology and products into the global marketplace. Pursuant to those appointments that company has committed 2,150,000
shares to be issued pursuant to a 2012 employee, consultant and director stock option plan, or for services rendered, subject to
Director approval.</p>
<p style="margin: 0pt"> </p>